Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amobarbital
Drug ID BADD_D00126
Description A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
Indications and Usage
Marketing Status Not Available
ATC Code N05CA02
DrugBank ID DB01351
KEGG ID D00555
MeSH ID D000654
PubChem ID 2164
TTD Drug ID D0R6BR
NDC Product Code Not Available
Synonyms Amobarbital | Amylobarbitone | Placidel | Amobarbital Sodium | Sodium, Amobarbital | Sodium Amobarbital | Amobarbital, Sodium | Amsal | Amylbarb sodium | Amylobeta | Amytal | Amytal Sodium | Sodium Amytal | Barbamyl | Eunoctal | Isoamitil Sedante | Isonal | Neur-Amyl | Novamobarb | Pentymal | Transital
Chemical Information
Molecular Formula C11H18N2O3
CAS Registry Number 57-43-2
SMILES CCC1(C(=O)NC(=O)NC1=O)CCC(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pneumothorax22.05.02.003--
Rash23.03.13.001--Not Available
Respiratory failure22.02.06.002; 14.01.04.003--
Shock24.06.02.002--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Tension19.06.02.005--Not Available
Thinking abnormal19.10.03.001; 17.02.05.023--Not Available
Vomiting07.01.07.003--
Liver injury12.01.02.003; 09.01.07.022--Not Available
The 2th Page    First    Pre   2    Total 2 Pages